PATH
Menu

PATH will join an international gathering of malaria researchers, policymakers, and others at the sixth Pan-African Multisectoral Initiative on Malaria (MIM) conference in Durban, South Africa, from October 6–11.

The conference theme—“Moving toward malaria elimination: Investing in research and control”—highlights the significant progress made in fighting the disease during the 15 years since the inaugural MIM conference, with many countries now committing to malaria elimination.

Our featured work

PATH staff will co-host or participate in the following events:

The PATH Malaria Vaccine Initiative:

  • A symposium on multistage, multicomponent malaria vaccines. October 7, 11:30 am to 1 pm.
  • A symposium on the updated Malaria Vaccine Technology Roadmap. October 9, 5 to 6:30 pm.
  • A poster presentation: “Community perceptions of malaria and vaccines in regions of Burkina Faso, Ghana, Kenya, and Mozambique, and implications for communication strategies regarding a future malaria vaccine.” October 9 during tea and lunch breaks.

The Malaria Control and Evaluation Partnership in Africa (MACEPA), a program at PATH:

  • A symposium co-sponsored by MACEPA and the Malaria Eradication Scientific Alliance called “Innovations in Malaria Eradication Research in Africa.” Duncan Earle, MACEPA program director, will serve as chair of the symposia and Busiku Hamainza, operations research technical officer for the Zambia National Malaria Control Centre will deliver a presentation on the country’s elimination work. Additionally, speakers from Senegal, South Africa, and Zanzibar’s malaria control programs will provide perspectives on subnational elimination efforts and approaches to ending transmission. October 7, 3 to 4:30 pm.

PATH’s Drug Development program:

  • A symposium featuring PATH’s Drug Development program, the South African Regional Network of Roll Back Malaria, and Institut Pasteur de Madagascar called “Multilateral Partnerships for Malaria Elimination.” Speakers will discuss three examples of public-private partnerships to achieve concrete results toward malaria elimination, including PATH’s work to develop semisynthetic artemisinin to stabilize availability and accessibility of lifesaving malaria drugs. October 8, 1:15 to 2:45 pm.

More information

Posted October 6, 2013.